AP Insights, News, Videos, and More

Delix Therapeutics has been awarded a $320,000 grant from the National Institute on Drug Abuse to support the advancement of its novel neuroplastogen and non-hallucinogenic ibogaine analog, DLX-007.

While Monitoring the Future survey data show adolescent past-year use rates are down, NIDA researchers caution that the emergence of illicit fentanyl has disproportionately driven up teen overdose deaths.

A behavioral intervention that integrates mindfulness, emotion regulation, and savoring of natural rewards could help reduce relapse rates in women receiving MAT for OUD, according to new research from Rutgers University.

Penn Medicine researchers suggest intense opioid withdrawal symptoms fueled by fentanyl are causing patients to leave the hospital early.

A reformulation of the prescription opioid OxyContin that caused users to seek illicit alternatives led to an increase in rates of child neglect and altered living arrangements, which, in part, fueled an increase in child suicides, according...

Oral nicotine pouches, an increasingly popular, smoke-free and tobacco-free alternative to cigarettes, do little to curb current smokers’ nicotine cravings, according to a recent study.

Drug overdose deaths among women and girls between the ages of 10 and 44 who were pregnant or pregnant within the past 12 months soared from 2018 to 2021, according to a NIDA study.